| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 10/29/2009 | US20090270619 Method for producing alpha form crystals of sapropterin hydrochloride |
| 10/27/2009 | US7608687 Releasable linkage and compositions containing same |
| 10/21/2009 | EP2109612A2 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors |
| 10/21/2009 | EP2109466A2 Positron emission tomography imaging method |
| 10/13/2009 | US7601834 Methotrexate orotate; improve bioavailability and drug clearance thereby reducing toxicity in cancer patients and in non-infectious, non-neoplastic inflammatory conditions such as rheumatoid arthritis, psoriasis, systemic lupus, and multiple sclerosis |
| 10/08/2009 | US20090253694 Fused hetrocyclic compounds |
| 10/01/2009 | US20090242837 Charge transport compositions and electronic devices made with such compositions |
| 09/30/2009 | EP2104502A1 Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives |
| 09/30/2009 | CN101544642A 4-pteridine-ammonia compound and preparation and application thereof |
| 09/23/2009 | EP2102210A2 Compounds useful as protein kinase inhibitors |
| 09/23/2009 | CN101541800A Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
| 09/16/2009 | CN101531661A Preparation method of tetrahydrofolic acid |
| 09/11/2009 | WO2009080367A3 Specific inhibitors of pteridine reductase with antiparasitic action |
| 09/10/2009 | US20090227579 Pteridine Derivatives and their Use as Cathespin Inhibitors |
| 09/10/2009 | US20090227539 Boron compounds useful in bnct |
| 09/09/2009 | EP1670799B1 Process for the purification of riboflavin |
| 09/09/2009 | CN100537570C Dihydropteridinones, method for the production and use thereof in the form of drugs |
| 09/08/2009 | US7585973 chemical synthesis for forming a conjugate of anticancer drug with folic acid; chemotherapy drug |
| 09/02/2009 | EP2094715A2 Dipterinyl calcium pentahydrate (dcp) and therapeutic methods based thereon |
| 08/27/2009 | WO2009103334A1 Folates, compositions and uses thereof |
| 08/27/2009 | WO2009103333A1 Process for the diastereoisomeric resolution of 5-methyltetrahydrofolic acid |
| 08/27/2009 | CA2712714A1 Folates, compositions and uses thereof |
| 08/25/2009 | US7579342 Pteridine compounds for the treatment of psoriasis |
| 08/20/2009 | US20090209543 Folates, compositions and uses thereof |
| 08/12/2009 | EP2087908A1 Antibodies to opgl |
| 08/06/2009 | US20090198055 Method of synthesizing tetrahydrobiopterin |
| 08/06/2009 | US20090196879 B-cell depleting agents, like anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome |
| 07/22/2009 | EP2079743A1 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
| 07/22/2009 | EP2079742A1 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
| 07/15/2009 | EP2078018A1 Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors |
| 07/15/2009 | CN100512879C Conjugate having cleavable linkage for use in liposome |
| 07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
| 07/09/2009 | WO2009022185A3 6, 6-fused heterocycles, their pharmaceutical compositions and methos of use |
| 07/09/2009 | US20090176790 Pterin analogs |
| 07/07/2009 | US7557115 Compounds for modulation of kinesins as anticancer agents with administering |
| 07/02/2009 | WO2009080367A2 Specific inhibitors of pteridine reductase with antiparasitic action |
| 06/25/2009 | WO2008125617A3 18f-labelled folates |
| 06/18/2009 | US20090156595 Pteridines useful as HCV inhibitors and methods for the preparation thereof |
| 06/17/2009 | EP1590341B1 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation |
| 06/16/2009 | US7547780 Dihydropteridione intermediate compounds |
| 06/11/2009 | WO2009071480A2 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors |
| 06/10/2009 | CN100497337C Folacin dimethylbiguanide and process for production thereof |
| 06/09/2009 | US7544312 Charge transport compositions and electronic devices made with such compositions |
| 06/03/2009 | EP2065365A2 Functional monomers for molecular recognition and catalysis |
| 06/03/2009 | CN101448830A Dihydropteridine compounds as anti proliferative agents |
| 06/02/2009 | US7541360 2-amino-4-N-cyclohexylmethylamino-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-pteridine; treatment of pathological blood pressure decreases, such as occur in septic or hemorrhagic shock, in tumor or cancer therapy with cytokines, liver cirrhosis; ulcerative colitis; NO synthase inhibitor |
| 05/27/2009 | CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/21/2009 | US20090131444 Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
| 05/20/2009 | EP2060272A2 Vitamin-mitomycin conjugates |
| 05/20/2009 | CN100488964C N2-arylformyl-4-ammonia/amidopteridine compound capable of regulating nitrous oxide synthase acitivity |
| 05/14/2009 | US20090124628 polo-like kinase inhibitors used as antiproliferative and antitumor agents |
| 05/14/2009 | US20090121617 Electronic devices made with electron transport and/or anti-quenching layers |
| 05/13/2009 | EP1305026B1 Barbituric acid analogs as therapeutic agents |
| 05/07/2009 | WO2008009079A3 Substituted pteridines useful for the treatment and prevention of viral infections |
| 04/23/2009 | US20090105124 Heterocyclic modulators of tgr5 |
| 04/22/2009 | CN101412716A Method for extracting lactoflavin |
| 04/16/2009 | WO2009047902A1 Method for producing pteridine compound and method for producing l-biopterin |
| 04/16/2009 | WO2009046581A1 A process for resolution of (6r,s)-5-formyltetrahydrofolic acid and its salification |
| 04/15/2009 | EP1869048B8 Method for producing alpha form crystals of sapropterin hydrochloride |
| 04/15/2009 | CN101407518A Method for resolving and salifying (6R,S)-5-formyl-tetrahydrofolic acid |
| 04/09/2009 | US20090093414 methotrexate- alpha -PhePhe-NHC10H20O3NHCO O-hyaluronic acid; therapeutical agent; oseoarthritis (degenerative diseases ) |
| 04/09/2009 | DE4448032B4 Zusammensetzung enthaltend organische Materialien und 3-Aryl-benzofuranone als Stabilisatoren A composition comprising organic materials and 3-aryl-benzofuranones as stabilizers |
| 04/08/2009 | EP1389209B1 Folate mimetics and folate-receptor binding conjugates thereof |
| 04/08/2009 | CN101405284A Pyrimidine, quinazoline, pteridine and derivatives |
| 04/02/2009 | WO2009041905A1 Pteridine compounds having activity on the gaba- receptors |
| 04/02/2009 | WO2009041666A1 Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent |
| 04/02/2009 | US20090088439 Diazinane Compounds |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | US20090081145 Process for forming disulphide bridges |
| 03/25/2009 | EP1504010B1 Vitamin-mitomycin conjugates |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/11/2009 | EP2032585A2 Substituted pteridines as therapeutic agents |
| 03/10/2009 | US7501513 Immunosuppressive effects of pteridine derivatives |
| 03/04/2009 | EP2029600A1 Substituted pteridines substituted with a four-membered heterocycle |
| 03/04/2009 | EP2029599A1 Dihydropteridine compounds as anti proliferative agents |
| 03/04/2009 | CN101379064A Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation |
| 02/26/2009 | US20090054385 Solid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | US20090053143 Liquid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/19/2009 | WO2009022185A2 6, 6-fused heterocycles, their pharmaceutical compositions and methos of use |
| 02/17/2009 | US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease |
| 02/17/2009 | CA2400217C Pteridine compounds for the treatment of psoriasis |
| 02/12/2009 | WO2009019205A1 Crystalline form of a dihydropteridione derivative |
| 02/12/2009 | US20090042890 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/12/2009 | CA2695406A1 Crystalline form of a dihydropteridione derivative |
| 02/04/2009 | CN101360747A Methods and compositions for the production of high concentration alloxazine solutions |
| 02/04/2009 | CN101360746A Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 01/29/2009 | US20090030004 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
| 01/28/2009 | EP2018858A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic trioxide |
| 01/28/2009 | CN101352572A Method for preparing folacin-carboxyl complexes |
| 01/14/2009 | EP1477568B1 Process for producing riboflavin |
| 01/08/2009 | US20090011421 Susceptibility to bone damage |
| 12/31/2008 | EP2008210A1 Modulation of phosphoryl transferase activity of glutamine synthetase |
| 12/25/2008 | US20080319193 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 12/17/2008 | CN101323614A Acidum folicum production method without sewerage discharge |
| 12/11/2008 | US20080306263 Process For The Preparation Of Optically Pure Tetrahydropterins And Derivatives, And Specifically Of Optically Pure Tetrahydrofolic Acid And Derivatives Thereof, By Stereospecific Hydrogenation |
| 12/04/2008 | WO2008146914A1 Heterocyclic compound |
| 12/04/2008 | WO2008144953A1 Process for preparing the stable, amorphous calcium salt of (6s)-n(5)-methyl-5,6,7,8-tetrahydrofolic acid |
| 12/03/2008 | CN101314602A Purification process for derivant of isoalloxazin ribitol |